selected publications
-
Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures.
Genome biology.
2016
Academic Article
GET IT
Times cited: 749 -
Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma.
European urology.
2016
Academic Article
GET IT
Times cited: 175 -
Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets.
Nature communications.
2016
Academic Article
GET IT
Times cited: 167 -
Tumor Xenografts of Human Clear Cell Renal Cell Carcinoma But Not Corresponding Cell Lines Recapitulate Clinical Response to Sunitinib: Feasibility of Using Biopsy Samples.
European urology focus.
2016
Academic Article
GET IT
Times cited: 32 -
Tumor genetic analyses of patients with metastatic renal cell carcinoma and extended benefit from mTOR inhibitor therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2014
Academic Article
GET IT
Times cited: 186 -
Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma.
European urology.
2012
Academic Article
GET IT
Times cited: 190